A new $7.4 billion settlement with states has been reached with Purdue Pharma and its Sackler family owners. We'll unpack.

OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and ...

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma, the company’s ...

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running ...

The Sackler family and Purdue Pharma have agreed to a $7.4 billion settlement to resolve federal claims brought by attorneys ...

Purdue Pharma and the Sackler family have agreed to increase by over $1 billion after the Supreme Court overturned a prior ...

Prescription opioid overdoses have killed thousands of Utahns. A new settlement puts a price tag on their lives and could bring "justice" to their families." ...

The Sackler family and Purdue Pharma, maker of OxyContin, have increased their settlement offer to $7.4 billion amid ongoing ...

Pennsylvania may receive up to $212 million over 15 years as part of a multi-state lawsuit settlement with Purdue Pharma and ...